![]() |
|
#1
|
|||
|
|||
|
(Reuters) - French drugmaker Sa**fi *and its U.S. partner Regeneron Pharmaceuticals could win U.S. approval for their keenly awaited new eczema drug dupilumab, seen by analysts as a potential $3 billion-a-year seller, by next March. ??????? ??????: Sa**fi may win U.S. approval of $3 billion eczema drug by March || ??????: ahlam1399 || ??????: اسم منتداك
|
![]() |
|
|